Our goal is to address serious medical conditions, across multiple and diverse therapeutic areas. Our
FDA-approved medicines are only the beginning of our long-term commitment to solve the human body's
most complex mysteries.
To achieve our mission to repeatedly bring important new medicines to patients with serious diseases, we remain committed to running our business responsibly and operating with the highest standards of integrity. This commitment underscores our philosophy of ‘doing well by doing good,’ every day.
Chair, Department of Molecular Biology, and Squibb Professor in Molecular Biology, Princeton University
Bonnie L. Bassler, Ph.D., joined the Board in September 2016. Dr. Bassler is the Chair of the Department of Molecular Biology and the Squibb Professor in Molecular Biology at Princeton University, and a Howard Hughes Medical Institute Investigator. Dr. Bassler has previously served on the Boards for the American Association for the Advancement of Science, the National Science Foundation and the American Academy of Microbiology. Dr. Bassler also served as the President of the American Society for Microbiology. She has been elected to the National Academy of Sciences, the American Academy of Arts and Sciences, the Royal Society and the American Philosophical Society. Dr. Bassler has received many scientific honors, including a MacArthur Foundation Fellowship, the Lounsbery Award and the Shaw Prize for Life Science and Medicine.
Dr. Bassler received her B.Sc. from the University of California, Davis, and her Ph.D. in Biochemistry from the Johns Hopkins University. She served as a Postdoctoral Fellow and Research Scientist at the Agouron Institute in La Jolla, California, before becoming a faculty member at Princeton University.